gemcitabine has been researched along with fosbretabulin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Guo, H; Sun, S; Wang, G | 1 |
| Alami, M; Boissenot, T; Brion, JD; Couvreur, P; Desmaële, D; Hamze, A; Maksimenko, A; Mougin, J; Provot, O; Pruvost, A; Zouhiri, F | 1 |
1 review(s) available for gemcitabine and fosbretabulin
| Article | Year |
|---|---|
Current status of carbazole hybrids as anticancer agents.
Topics: Antineoplastic Agents; Carbazoles; Cell Cycle Checkpoints; Cell Proliferation; Coumarins; Humans; Indoles; Pyrazoles; Pyrimidines; Structure-Activity Relationship | 2022 |
1 other study(ies) available for gemcitabine and fosbretabulin
| Article | Year |
|---|---|
Therapeutic modalities of squalenoyl nanocomposites in colon cancer: an ongoing search for improved efficacy.
Topics: Animals; Antineoplastic Agents; Biological Transport; Cell Line, Tumor; Cell Proliferation; Colonic Neoplasms; Deoxycytidine; Drug Carriers; Drug Design; Gemcitabine; Humans; Intracellular Space; Mice; Nanocomposites; Squalene; Stilbenes; Xenograft Model Antitumor Assays | 2014 |